Literature DB >> 2199027

Coffee and tea consumption in relation to the risk of large bowel cancer: a review of epidemiologic studies.

L Rosenberg1.   

Abstract

Most of the few epidemiologic investigations of the relation of methylxanthine ingestion to risk of large bowel cancer have concerned coffee consumption. A slightly increased risk in coffee drinkers was suggested by one study, no association by another and an inverse association by four, but there was a statistically significant trend across levels of consumption in only one of the latter studies. Based on the data on hand, there is little reason for concern that coffee consumption increases the risk. Although some evidence suggests an inverse association, the data are not compelling and a biologic mechanism is not established. There is even less information on tea consumption and the relation of consumption of this beverage to risk of large bowel cancer is unknown.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2199027     DOI: 10.1016/0304-3835(90)90183-x

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  5 in total

Review 1.  Complementary and alternative medicines in prostate cancer: from bench to bedside?

Authors:  Samuel J Klempner; Glenn Bubley
Journal:  Oncologist       Date:  2012-05-22

2.  Coffee and cancer: a prospective study of 43,000 Norwegian men and women.

Authors:  I Stensvold; B K Jacobsen
Journal:  Cancer Causes Control       Date:  1994-09       Impact factor: 2.506

Review 3.  Selected health and behavioral effects related to the use of caffeine.

Authors:  R J Lamarine
Journal:  J Community Health       Date:  1994-12

Review 4.  Inhibition of carcinogenesis by tea constituents.

Authors:  Jihyeung Ju; Gang Lu; Joshua D Lambert; Chung S Yang
Journal:  Semin Cancer Biol       Date:  2007-07-04       Impact factor: 15.707

5.  Relationship of diet to small and large adenomas of the sigmoid colon.

Authors:  S Kono; K Imanishi; K Shinchi; F Yanai
Journal:  Jpn J Cancer Res       Date:  1993-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.